{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "HKD", "exchange": "HKG", "shortName": "KINTOR PHARMA-B", "longName": "Kintor Pharmaceutical Limited", "messageBoardId": "finmb_108801544", "market": "hk_market", "marketState": "CLOSED", "earningsTimestamp": 1682693139, "earningsTimestampStart": 1682693139, "earningsTimestampEnd": 1682693139, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -3.01, "epsForward": -1.86, "epsCurrentYear": -2.06, "priceEpsCurrentYear": -2.2815533, "sharesOutstanding": 447500000, "bookValue": 3.341, "fiftyDayAverage": 6.8242, "fiftyDayAverageChange": -2.1242003, "fiftyDayAverageChangePercent": -0.31127462, "twoHundredDayAverage": 11.01685, "tradeable": false, "cryptoTradeable": false, "exchangeTimezoneName": "Asia/Hong_Kong", "exchangeTimezoneShortName": "HKT", "gmtOffSetMilliseconds": 28800000, "esgPopulated": false, "regularMarketChangePercent": -7.6620893, "regularMarketPrice": 4.7, "regularMarketChange": -0.39000034, "regularMarketTime": 1683878916, "regularMarketDayHigh": 5.34, "regularMarketDayRange": "4.67 - 5.34", "regularMarketDayLow": 4.67, "regularMarketVolume": 13651000, "regularMarketPreviousClose": 5.09, "bid": 4.7, "ask": 4.72, "fullExchangeName": "HKSE", "financialCurrency": "CNY", "regularMarketOpen": 5.27, "averageDailyVolume3Month": 5621794, "averageDailyVolume10Day": 5123070, "fiftyTwoWeekLowChange": 0.029999733, "fiftyTwoWeekLowChangePercent": 0.0064239255, "fiftyTwoWeekRange": "4.67 - 24.6", "fiftyTwoWeekHighChange": -19.900002, "fiftyTwoWeekHighChangePercent": -0.80894315, "fiftyTwoWeekLow": 4.67, "fiftyTwoWeekHigh": 24.6, "twoHundredDayAverageChange": -6.3168507, "twoHundredDayAverageChangePercent": -0.5733808, "marketCap": 2103249920, "forwardPE": -2.5268817, "priceToBook": 1.4067644, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "2.0 - Buy", "firstTradeDateMilliseconds": 1590111000000, "priceHint": 3, "symbol": "9939.HK"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "No. 20 Songbei Road", "address2": "Suzhou Industrial Park", "city": "Suzhou", "zip": "215123", "country": "China", "phone": "86 51 2626 39909", "website": "https://www.kintor.com.cn", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Kintor Pharmaceutical Limited, a clinical-stage biotechnology company, engages in developing and commercializing a pipeline of small molecule and biological therapeutics for androgen-receptor-related disease areas with unmet medical needs in the People's Republic of China and internationally. The company's products pipeline include Proxalutamide, a second generation androgen receptor (AR) antagonist for the treatment of metastatic castration-resistant prostate cancer, AR positive breast cancer, and COVID-19; and Pyrilutamide, an AR antagonist for the androgenetic alopecia (AGA) and acne vulgaris treatment. Its products pipeline also comprise ALK-1 antibody for the treatment of metastatic hepatocellular carcinoma (HCC) and various solid tumours; GT20029, a topical AR-PROTAC compound for the treatment of AGA and acne vulgaris; and PD-L1/TGF-\u00df, a dual target antibody to treat non-small cell lung cancer, biliary tract cancer, triple negative breast cancer, and HPV-associated tumours. In addition, the company's products pipeline include Detorsertib for the treatment of metastatic solid tumours, such as breast cancer, prostate cancer, and HCC; and Hedgehog/SMO Inhibitor, an inhibitor of the hedgehog signal transduction pathway to treat blood cancer and basal-cell carcinoma. Kintor Pharmaceutical Limited was founded in 2009 and is headquartered in Suzhou, the People's Republic of China.", "fullTimeEmployees": 301, "companyOfficers": [{"maxAge": 1, "name": "Dr. Youzhi  Tong", "age": 59, "title": "Founder, CEO & Exec. Chairman", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": {"raw": 1024314, "fmt": "1.02M", "longFmt": "1,024,314"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ming Ming  Cheung", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1977, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Qun  Lu", "age": 56, "title": "CTO & Exec. Director", "yearBorn": 1966, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Xiang  Ni", "age": 53, "title": "Chief Medical Officer & Exec. Director", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Zhihua  Ren", "title": "VP and Head of Institute of R&D", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Wai Chiu  Wong FCS", "age": 66, "title": "Company Sec.", "yearBorn": 1956, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}